Trial Profile
A Phase II Study of Chemoimmunotherapy for Patients With Potentially Platinum Sensitive Müllerian (Epithelial Ovarian, Peritoneal, or Fallopian Tube) Carcinomas.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Interferon gamma (Primary) ; Sargramostim (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 21 Aug 2009 Actual end date (1 Jan 2009) added as reported by ClinicalTrials.gov.
- 21 Aug 2009 Actual patient number (59) added as reported by ClinicalTrials.gov.
- 17 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.